Fennec Pharmaceuticals
FENC
52 hedge funds and large institutions have $89.2M invested in Fennec Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 13 increasing their positions, 20 reducing their positions, and 5 closing their positions.
0% more funds holding
Funds holding: 52 → 52 (0)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 5
0.41% less ownership
Funds ownership: 56.1% → 55.69% (-0.41%)
17% less capital invested
Capital invested by funds: $108M → $89.2M (-$18.6M)
35% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 20
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
+$986K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$279K |
| 3 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$275K |
| 4 |
BlackRock
New York
|
+$192K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$104K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$1.34M |
| 2 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$602K |
| 3 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
-$211K |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$165K |
| 5 |
Russell Investments Group
London,
United Kingdom
|
-$163K |
FENC Hedge Fund Activity: Q1 2021 in Review
52 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Fennec Pharmaceuticals (FENC) for Q1 2021, worth a combined $89.2M — down 17% from $108M a quarter earlier.
Fund positioning in FENC was balanced in Q1 2021: 5 funds opened new positions, 5 closed out, 13 added to existing stakes and 20 trimmed.
The largest buyer was Wells Fargo, adding an estimated $986K. The largest seller was Granahan Investment Management, cutting an estimated $1.34M.
- 52 institutional investors held Fennec Pharmaceuticals (FENC) as of Q1 2021, unchanged from Q4 2020.
- Funds reported $89.2M of Fennec Pharmaceuticals stock for Q1 2021, down 17% quarter-over-quarter.
- 5 funds opened new Fennec Pharmaceuticals positions in Q1 2021 and 5 closed out, a net change of 0 holders.
- The largest Fennec Pharmaceuticals buyer in Q1 2021 was Wells Fargo, an estimated $986K added.
- The largest Fennec Pharmaceuticals seller in Q1 2021 was Granahan Investment Management, an estimated $1.34M sold.
Based on aggregated 13F filings for Q1 2021.